Gonzalo Escalante
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gonzalo Escalante has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Alan Marcelo Szalai
Centro de Investigaciones en Bionanociencias (CIBION), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Godoy Cruz 2390, C1425FQD Ciudad Autónoma de Buenos Aires, Argentina
3 shared publications - Fernando Daniel Stefani
Centro de Investigaciones en Bionanociencias (CIBION), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina
3 shared publications - Lucia Fernanda Lopez
Centro de Investigaciones en Bionanociencias (CIBION), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Godoy Cruz 2390, C1425FQD Ciudad Autónoma de Buenos Aires, Argentina
2 shared publications - Antonia Marin-Burgin
Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society
1 shared publication - Cayetana Arnaiz
Department of Cell and Developmental Biology, Vanderbilt University
1 shared publication - Clara Gaguine
Instituto de Investigación en Biomedicina de Buenos Aires IBioBA (MPSP-CONICET), Partner Institute of the Max Planck Society, Buenos Aires, Argentina
1 shared publication
Latest Publications
- Open Access
Tau isoforms modulate the axon initial segment controlling axonal trafficking and neuronal excitability
The axon initial segment (AIS) is a specialized neuronal compartment integrating action potential initiation with selective control of axonal trafficking. The microtubule-associated protein tau is a central regulator of cytoskeletal organization and transport, yet how distinct tau isoforms contribute to AIS development and function remains unclear. Here, we examined the role of tau isoform relative abundance in regulating AIS establishment, maturation, excitability, and transport selectivity using murine primary neurons and human induced pluripotent stem cell (hiPSC)-derived neurons combined with super-resolution imaging, electrophysiology, and live trafficking assays. We found that tau expression levels and isoform content modulate the timing and robustness of AIS maturation. In murine neurons, tau deficiency or predominance of 3-repeat (3R) tau delays Ankyrin-G accumulation and AIS stabilization without preventing AIS formation. hiPSC-derived neurons display an intrinsic AIS developmental program accompanied by progressive changes in tau isoform content. Super-resolution DNA-PAINT reveals that endogenous tau decorates axonal microtubules in discrete nanoclusters with compartment-specific distributions. Modulation of the endogenous 3R/4R tau balance in hiPSC-derived neurons shows that isoform composition, independently of tau levels, regulates AIS positioning and Ankyrin-G organization. Functionally, shifts towards 3R-tau reduce sodium currents, impairs action potential firing, and alters lysosomal transport dynamics within the AIS. Together, these findings identify tau isoform balance as a developmental regulator of AIS maturation, linking cytoskeletal organization to neuronal excitability and transport gating. Because the aberrant alternative tau splicing of exon 10 is a defining feature of primary tauopathies, our results provide mechanistic insight into how imbalanced tau isoforms may contribute to neuronal dysfunction. Significant Statement: The axon initial segment (AIS) plays a central role in brain function by integrating action potential initiation with selective control of axonal trafficking. Disruption of tau splicing, resulting in altered ratios of tau isoforms, is a defining feature of several neurodegenerative diseases, yet its functional consequences remain poorly understood. Here, we show that balanced tau isoform expression is required for proper AIS maturation, neuronal excitability, and transport selectivity. By combining a human neuronal model, super-resolution imaging, electrophysiology, and live transport analysis, our work identifies tau isoform balance as a key regulator of AIS development. These findings provide mechanistic insight into how early tau dysregulation may initiate neuronal dysfunction in tauopathies and highlight the AIS as a potential therapeutic target.
Open AccessTau isoforms modulate the axon initial segment controlling axonal trafficking and neuronal excitability
The axon initial segment (AIS) is a specialized neuronal compartment integrating action potential initiation with selective control of axonal trafficking. The microtubule-associated protein tau is a central regulator of cytoskeletal organization and transport, yet how distinct tau isoforms contribute to AIS development and function remains unclear. Here, we examined the role of tau isoform relative abundance in regulating AIS establishment, maturation, excitability, and transport selectivity using murine primary neurons and human induced pluripotent stem cell (hiPSC)-derived neurons combined with super-resolution imaging, electrophysiology, and live trafficking assays. We found that tau expression levels and isoform content modulate the timing and robustness of AIS maturation. In murine neurons, tau deficiency or predominance of 3-repeat (3R) tau delays Ankyrin-G accumulation and AIS stabilization without preventing AIS formation. hiPSC-derived neurons display an intrinsic AIS developmental program accompanied by progressive changes in tau isoform content. Super-resolution DNA-PAINT reveals that endogenous tau decorates axonal microtubules in discrete nanoclusters with compartment-specific distributions. Modulation of the endogenous 3R/4R tau balance in hiPSC-derived neurons shows that isoform composition, independently of tau levels, regulates AIS positioning and Ankyrin-G organization. Functionally, shifts towards 3R-tau reduce sodium currents, impairs action potential firing, and alters lysosomal transport dynamics within the AIS. Together, these findings identify tau isoform balance as a developmental regulator of AIS maturation, linking cytoskeletal organization to neuronal excitability and transport gating. Because the aberrant alternative tau splicing of exon 10 is a defining feature of primary tauopathies, our results provide mechanistic insight into how imbalanced tau isoforms may contribute to neuronal dysfunction. Significant Statement: The axon initial segment (AIS) plays a central role in brain function by integrating action potential initiation with selective control of axonal trafficking. Disruption of tau splicing, resulting in altered ratios of tau isoforms, is a defining feature of several neurodegenerative diseases, yet its functional consequences remain poorly understood. Here, we show that balanced tau isoform expression is required for proper AIS maturation, neuronal excitability, and transport selectivity. By combining a human neuronal model, super-resolution imaging, electrophysiology, and live transport analysis, our work identifies tau isoform balance as a key regulator of AIS development. These findings provide mechanistic insight into how early tau dysregulation may initiate neuronal dysfunction in tauopathies and highlight the AIS as a potential therapeutic target.
- Open Access
Distinct nanoscale organizations of mucins and trans-sialidases in Trypanosoma cruzi
Trypanosoma cruzi , the causative agent of Chagas disease, relies on surface sialylation to evade host immunity and invade cells. This process is mediated by trans-sialidases (TS) and mucins, an enzyme–substrate pair anchored to distinct lipid environments. Yet, how these molecules are organized at the nanoscale in the parasite’s membrane remains unknown. Using dual-color super-resolution microscopy, we show that ∼60% of mucins and TS are segregated into nanoclusters (∼100 nm) that rarely contact each other, distributed with a nonrandom separation distance, indicating that these abundant domains follow a specific order in the plasma membrane and are unlikely to serve as primary sites of sialylation. In contrast, the ∼40% fraction of non-clustered mucins and TS exhibits significantly shorter-than-random separation distances and appear ordered as in a shared fibrillar network. Additionally, we describe a distinct structural organization within these domains: mucins - residents of detergent-resistant domains (DRDs) - organize into high-molecular-weight complexes, whereas TS (which are excluded from DRDs) do not, suggesting a potential mechanism for domain-specific protein localization.
Open AccessDistinct nanoscale organizations of mucins and trans-sialidases in Trypanosoma cruzi
Trypanosoma cruzi , the causative agent of Chagas disease, relies on surface sialylation to evade host immunity and invade cells. This process is mediated by trans-sialidases (TS) and mucins, an enzyme–substrate pair anchored to distinct lipid environments. Yet, how these molecules are organized at the nanoscale in the parasite’s membrane remains unknown. Using dual-color super-resolution microscopy, we show that ∼60% of mucins and TS are segregated into nanoclusters (∼100 nm) that rarely contact each other, distributed with a nonrandom separation distance, indicating that these abundant domains follow a specific order in the plasma membrane and are unlikely to serve as primary sites of sialylation. In contrast, the ∼40% fraction of non-clustered mucins and TS exhibits significantly shorter-than-random separation distances and appear ordered as in a shared fibrillar network. Additionally, we describe a distinct structural organization within these domains: mucins - residents of detergent-resistant domains (DRDs) - organize into high-molecular-weight complexes, whereas TS (which are excluded from DRDs) do not, suggesting a potential mechanism for domain-specific protein localization.
- Open Access
Nanoscale organization of betaII-spectrin within segments of the membrane-associated periodic skeleton in mouse sciatic nerve axons
The actin/spectrin membrane-associated periodic skeleton (MPS) is a ubiquitous cytoskeletal structure essential for axonal integrity and function. Primarily studied in cultured neurons, the MPS has been extensively modeled as actin rings spaced by spectrin tetramers, the latter assumed to be regularly and densely distributed across the axonal perimeter. However, its nanoscale organization within native tissue environments remains poorly understood. In this study, we investigated the three-dimensional organization of βII-spectrin in the mouse sciatic nerve using 3D-dSTORM and STED super-resolution microscopy on thin transversal cryosections. By implementing a custom quantitative analysis pipeline, we resolved the sub-diffraction architecture of the MPS across myelinated axons of diverse diameters. We confirm that βII-spectrin is localized to the inner face of the axonal plasma membrane and maintains a longitudinal periodicity of approximately 170 nm, consistent with previous observations. Crucially, 3D-dSTORM revealed that βII-spectrin along the axonal perimeter is organized in discrete nanoscale clusters with a median effective radius of 25 nm, compatible with the size of an individual spectrin tetramer visualized by indirect immunolabeling. The number of these clusters scales linearly with the axonal perimeter, maintaining a constant membrane occupancy of ∼20% across varying axon diameters. Moreover, these clusters exhibit a non-random spatial distribution with a characteristic center-to-center nearest-neighbor distance of ∼200 nm. These findings challenge simplified models of the MPS based on cultured systems and demonstrate that the MPS in peripheral nerves is composed of discrete structural units. This modular, dispersed organization may provide the structural flexibility required to withstand the mechanical demands of the peripheral nervous system while maintaining a stable periodic scaffold.
Open AccessNanoscale organization of betaII-spectrin within segments of the membrane-associated periodic skeleton in mouse sciatic nerve axons
The actin/spectrin membrane-associated periodic skeleton (MPS) is a ubiquitous cytoskeletal structure essential for axonal integrity and function. Primarily studied in cultured neurons, the MPS has been extensively modeled as actin rings spaced by spectrin tetramers, the latter assumed to be regularly and densely distributed across the axonal perimeter. However, its nanoscale organization within native tissue environments remains poorly understood. In this study, we investigated the three-dimensional organization of βII-spectrin in the mouse sciatic nerve using 3D-dSTORM and STED super-resolution microscopy on thin transversal cryosections. By implementing a custom quantitative analysis pipeline, we resolved the sub-diffraction architecture of the MPS across myelinated axons of diverse diameters. We confirm that βII-spectrin is localized to the inner face of the axonal plasma membrane and maintains a longitudinal periodicity of approximately 170 nm, consistent with previous observations. Crucially, 3D-dSTORM revealed that βII-spectrin along the axonal perimeter is organized in discrete nanoscale clusters with a median effective radius of 25 nm, compatible with the size of an individual spectrin tetramer visualized by indirect immunolabeling. The number of these clusters scales linearly with the axonal perimeter, maintaining a constant membrane occupancy of ∼20% across varying axon diameters. Moreover, these clusters exhibit a non-random spatial distribution with a characteristic center-to-center nearest-neighbor distance of ∼200 nm. These findings challenge simplified models of the MPS based on cultured systems and demonstrate that the MPS in peripheral nerves is composed of discrete structural units. This modular, dispersed organization may provide the structural flexibility required to withstand the mechanical demands of the peripheral nervous system while maintaining a stable periodic scaffold.